...
首页> 外文期刊>Cardiovascular and Interventional Radiology: A Journal of Imaging in Diagnosis and Treatment >Simultaneous biliary drainage and portal vein embolization before extended hepatectomy for hilar cholangiocarcinoma: Preliminary experience
【24h】

Simultaneous biliary drainage and portal vein embolization before extended hepatectomy for hilar cholangiocarcinoma: Preliminary experience

机译:肝门部胆管癌扩大肝切除术前同时胆道引流和门静脉栓塞的初步经验

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: Patients with resectable hilar cholangiocarcinoma often present obstructive jaundice and a small future remnant liver (FRL) ratio. A sequential approach comprising preoperative biliary drainage followed by portal vein embolization (PVE) is usually performed but leads to long preoperative management (6-12 weeks) before patients can undergo resection. To simplify and shorten this phase of liver preparation, we developed a new preoperative approach that involves percutaneous biliary drainage and PVE during the same procedure. We report the outcomes of this combined procedure. Methods: During 1 year, four patients underwent simultaneous biliary drainage and PVE followed 1 month later by surgical resection of hilar cholangiocarcinoma. Liver volumes were assessed by CT before, and 1, and 3 months after the combined procedure. Serum liver enzymes were assessed before and 1 month after the combined procedure. Results: The combined procedure was feasible in all cases, with no related complications. After the combined procedure, transaminases remained stable or decreased, whereas gamma-glutamyl-transpeptidase, alkaline phosphatase, and bilirubin decreased. During the first month, the left lobe volume increased by +27.9 % (range 19-40.9 %). The FRL ratio increased from 24.9 to 33.2 %. All patients underwent R0 liver resection with a favorable postoperative outcome. The remnant liver volume increased by +132 % (range 78-245 %) between 1 and 3 months. Conclusions: Simultaneous percutaneous biliary drainage and PVE is feasible. This all-in-one preoperative approach greatly decreases waiting time until surgical resection. These encouraging results warrant further investigation to confirm the safety and to evaluate the reduction in the dropout rate for liver resection in this tumor with poor prognosis.
机译:背景:可切除的肝门胆管癌患者常表现为梗阻性黄疸和较小的残留肝(FRL)比率。通常采用先行胆道引流,然后进行门静脉栓塞(PVE)的先后顺序方法,但会导致术前长期治疗(6-12周),然后才能进行患者切除。为了简化和缩短肝脏准备的这一阶段,我们开发了一种新的术前方法,其中涉及在同一过程中进行经皮胆道引流和PVE。我们报告了此联合程序的结果。方法:在1年中,有4例患者同时进行了胆道引流和PVE,随后1个月后进行了肝门胆管癌的手术切除。在合并手术前,合并后1、3个月通过CT评估肝脏体积。在联合手术之前和之后1个月评估血清肝酶。结果:联合手术在所有情况下均可行,无相关并发症。联合操作后,转氨酶保持稳定或下降,而γ-谷氨酰转肽酶,碱性磷酸酶和胆红素下降。在第一个月中,左叶体积增加了+27.9%(范围19-40.9%)。 FRL比率从24.9%增加到33.2%。所有患者均接受R0肝切除术,术后效果良好。在1到3个月之间,残余肝脏体积增加了+132%(范围为78-245%)。结论:同时经皮胆道引流和PVE是可行的。这种多合一的术前方法大大减少了手术切除之前的等待时间。这些令人鼓舞的结果值得进一步研究,以确认安全性并评估该预后不良肿瘤的肝切除术的辍学率降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号